IRIS
GAETA, Giovanni Battista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.517
NA - Nord America 7.464
AS - Asia 5.522
SA - Sud America 1.072
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 10
Totale 28.687
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.989
US - Stati Uniti d'America 7.330
SG - Singapore 1.995
IE - Irlanda 1.789
CN - Cina 1.308
HK - Hong Kong 1.022
UA - Ucraina 977
BR - Brasile 910
GB - Regno Unito 800
DE - Germania 542
VN - Vietnam 472
IT - Italia 368
SE - Svezia 292
FI - Finlandia 279
GR - Grecia 175
IN - India 165
TR - Turchia 150
FR - Francia 135
KR - Corea 98
CA - Canada 74
AR - Argentina 67
BD - Bangladesh 65
JP - Giappone 64
BE - Belgio 34
CZ - Repubblica Ceca 30
IQ - Iraq 30
ID - Indonesia 28
MX - Messico 28
AT - Austria 23
EC - Ecuador 22
IR - Iran 22
NL - Olanda 22
PL - Polonia 20
PY - Paraguay 19
PK - Pakistan 18
ZA - Sudafrica 17
EU - Europa 15
EG - Egitto 14
VE - Venezuela 14
MA - Marocco 13
CO - Colombia 11
TW - Taiwan 11
CL - Cile 9
TH - Thailandia 9
AU - Australia 8
DO - Repubblica Dominicana 8
PE - Perù 8
UZ - Uzbekistan 8
DZ - Algeria 7
ET - Etiopia 7
JM - Giamaica 7
PH - Filippine 7
UY - Uruguay 7
AZ - Azerbaigian 6
CH - Svizzera 6
ES - Italia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
JO - Giordania 5
RO - Romania 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
NP - Nepal 4
CI - Costa d'Avorio 3
GH - Ghana 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
NI - Nicaragua 3
OM - Oman 3
SA - Arabia Saudita 3
SN - Senegal 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
BF - Burkina Faso 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
Totale 28.676
Salva come PNG Salva come JPEG
Città #
Moscow 3.225
Dublin 1.783
Jacksonville 1.404
Hong Kong 1.014
Chandler 894
Singapore 735
Santa Clara 696
San Jose 558
Dallas 311
Princeton 271
Ashburn 263
Medford 236
Beijing 178
Ho Chi Minh City 161
Boardman 157
Roxbury 140
San Mateo 130
Wilmington 123
Ann Arbor 108
Hanoi 105
Hefei 105
Bengaluru 97
Seoul 96
New York 89
The Dalles 86
Woodbridge 83
Munich 79
Bremen 77
Cambridge 72
São Paulo 64
Nanjing 61
Des Moines 55
Los Angeles 53
Düsseldorf 47
Helsinki 47
Mountain View 40
Jinan 36
Brussels 34
Orem 33
Caserta 30
Brno 27
Nanchang 27
Rio de Janeiro 27
Venice 27
Da Nang 25
Haiphong 25
Napoli 25
Rome 25
Zhengzhou 25
Memphis 24
Shanghai 23
Belo Horizonte 22
Guangzhou 22
Shenyang 22
Norwalk 21
Naples 20
Atlanta 19
Milan 19
Changsha 18
Nuremberg 18
Tianjin 18
Turku 18
Campinas 17
Chennai 17
Curitiba 17
Kunming 17
Brasília 16
Porto Alegre 16
Hangzhou 14
Houston 13
Tokyo 13
Frankfurt am Main 12
Ningbo 12
Ninh Bình 12
Baghdad 11
Dhaka 11
Recife 11
Redwood City 11
Santo André 11
Guayaquil 10
Haikou 10
Hebei 10
Hải Dương 10
Ottawa 10
Asunción 9
Auburn Hills 9
Istanbul 9
Kraków 9
Padova 9
Shenzhen 9
Biên Hòa 8
Lanzhou 8
Manaus 8
Taizhou 8
Tashkent 8
Toronto 8
Vienna 8
Warsaw 8
Amsterdam 7
Brooklyn 7
Totale 14.686
Salva come PNG Salva come JPEG
Nome #
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 471
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 346
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 303
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 302
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 185
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 179
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 173
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 166
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 166
AISF position paper on HCV in immunocompromised patients 166
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 165
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 158
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 156
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 155
AISF position paper on liver disease and pregnancy 153
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP) 152
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 152
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 150
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 150
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 146
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas 146
[Prevalence and risk factors for bacteriuria in patients with cirrhosis] 144
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 142
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 141
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 141
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 141
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 141
Changing indications for liver transplant: slow decline of hepatitis viruses in Italy 141
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 138
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 138
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 137
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 137
Virological patterns of HCV patients with failure to interferon-free regimens. 136
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 134
[Cutaneous myiasis from Cordylobia anthropophaga in a traveller returning from Senegal: a case study] 134
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 133
Clinical and histological aspects of chronic HCV infection and cirrhosis 132
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 131
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 130
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 130
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 129
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 129
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 129
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 128
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 128
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 127
Hepatitis delta infection in Italian patients: towards the end of the story? 126
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir 126
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 125
[Visceral leishmaniasis: its epidemiology, clinical picture and therapy] 125
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3 125
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 124
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 124
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B 124
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 124
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. 123
[Cryptosporidium infection in immunocompetent and immunocompromised host] 122
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 122
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 121
Liver toxicity during copper chronic intoxication in rats 121
[Visceral leishmaniasis in Italy. Its epidemiology, clinical picture and therapy] 121
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 121
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 120
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 120
Fever of unknown origin: a systematic review of the literature for 1995-2004 120
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 120
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 120
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 120
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 119
Doctors in the kitchen. Experiments with cooking bivalve mollusks 119
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 119
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 119
Functional changes induced by taurolithocolic acid in the isolated perfused rat liver 118
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 118
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 118
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 117
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 117
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 117
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 117
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 117
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 116
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 116
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis 116
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 115
Hepatic excretory function in the endotoxin tolerant rat 115
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 114
Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. 114
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study 114
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 113
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 113
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 113
Interference of endotoxin pretreatment on the taurolithocholate induced cholestasis 111
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 110
Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts 109
Effect of chronic copper administration on excretory function of rat liver 109
The role of surgery in transmitting "post-transfusion" hepatitis 108
Prospective Validation of the CLIP Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators 108
Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the study of the liver) 107
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. 107
Tamoxifen in the treatmnent of hepatocellular carcinoma: 5 years results of the CLIP-1 multicentre randomised controlled trial 107
Totale 13.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 0 0 60
2021/20221.690 148 11 17 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/20241.143 113 34 51 110 438 75 10 35 4 25 57 191
2024/20253.550 58 53 34 102 502 309 582 308 526 622 263 191
2025/202614.272 407 516 929 762 1.133 8.376 689 351 552 268 204 85
Totale 28.976